Treatment with the selective serotonin reuptake inhibitor sertraline in the early phase of acute coronary syndromes: a double-blind, placebo-controlled pilot study

被引：0
|
作者：
Tanzi, P
Picano, A
Salvini, P
Terranova, A
Terrana, R
Cicini, MP
Mercuro, G
Pelliccia, F
机构：
来源：
EUROPEAN HEART JOURNAL | 2004年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：296 / 297
页数：2
相关论文
共 50 条
  • [1] Treatment with the selective serotonin reuptake inhibitor sertraline in the early phase of acute coronary syndromes: A double-blind, placebo-controlled, pilot study
    Pelliccia, F
    Picano, A
    Salvini, P
    Polletta, B
    Cartoni, D
    Cicini, MP
    Mercuro, G
    Tanzi, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 231A - 232A
  • [2] Interruption of selective serotonin reuptake inhibitor treatment - Double-blind, placebo-controlled trial
    Michelson, D
    Fava, M
    Amsterdam, J
    Apter, J
    Londborg, P
    Tamura, R
    Tepner, RG
    BRITISH JOURNAL OF PSYCHIATRY, 2000, 176 : 363 - 368
  • [3] A randomized double-blind placebo controlled trial of the selective serotonin reuptake inhibitor (SSRI) sertraline for major depression after acute coronary syndromes (ACS) - The SADHART trial
    O'Connor, CM
    Glassman, AH
    Harrison, WM
    CIRCULATION, 2001, 104 (17) : 344 - 344
  • [4] Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study
    Broekaert, D
    Fischler, B
    Sifrim, D
    Janssens, J
    Tack, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 365 - 370
  • [5] Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-Blind, Placebo-Controlled Study
    Viazis, Nikos
    Keyoglou, Anastasia
    Kanellopoulos, Alexandros K.
    Karamanolis, George
    Vlachogiannakos, John
    Triantafyllou, Konstantinos
    Ladas, Spiros D.
    Karamanolis, Dimitrios G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (11) : 1662 - 1667
  • [6] Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor for panic disorder - A double-blind placebo controlled trial
    Tsutsui, S
    Osada, H
    Muranaka, M
    Namiki, M
    Katsura, T
    Kamijima, K
    Shibuya, T
    JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 1997, 19 (06): : 639 - 657
  • [7] Treatment of functional dyspepsia with sertraline:A double-blind randomized placebo-controlled pilot study
    Victoria PY Tan
    Tin K Cheung
    Wai M Wong
    Roberta Pang
    Benjamin CY Wong
    World Journal of Gastroenterology, 2012, (42) : 6127 - 6133
  • [8] Treatment of functional dyspepsia with sertraline: A double-blind randomized placebo-controlled pilot study
    Tan, Victoria P. Y.
    Cheung, Tin K.
    Wong, Wai M.
    Pang, Roberta
    Wong, Benjamin C. Y.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (42) : 6127 - 6133
  • [9] Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor in the treatment of obsessive-compulsive disorder - A double-blind placebo controlled trial
    Ushijima, S
    Kamijima, K
    Asai, M
    Murasaki, M
    Nakajima, T
    Kudo, Y
    Tashiro, N
    Kurihara, M
    Miura, S
    JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 1997, 19 (06): : 603 - 623
  • [10] Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study
    Di Girolamo, E
    Di Iorio, C
    Sabatini, P
    Leonzio, L
    Barbone, C
    Barsotti, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (05) : 1227 - 1230
12345